HopeStage
Back to all studies
CompletedNCT00356278

Virtual-reality exposure with D-cycloserine or placebo for PTSD in veterans

About this titleRead the official source — NCT00356278
Medication studyAges 21–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 65 years.

Listed locations
AtlantaSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2006
Recruitment status
Completed
Enrollment listed in the registry
156
Sponsor
Emory University
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 21 Years to 65 Years
Official registry ID
NCT00356278
Official title
Show the full official title

A Cognitive Enhancer May Facilitate Behavioral Exposure Therapy for Veterans With PTSD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Atlanta

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Emory University, a university.

Did this study involve medication?

Yes. The study involved medication, including D-Cycloserine, Alprazolam and Placebo.

Who was this study for?

Listed age limits: 21 years to 65 years.

Want to explore more studies?

Explore studies